Latest Information Update: 30 Dec 2015
At a glance
- Originator Biolab Sanus Farmaceutica
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Benign prostatic hyperplasia; Erectile dysfunction; Hypertension; Pneumonia; Unspecified
Most Recent Events
- 01 Jan 2014 Preclinical trials in Undefined indication in Brazil (unspecified route)
- 01 Jan 2014 Preclinical trials in Pneumonia in Brazil (unspecified route)
- 01 Jan 2014 Preclinical trials in Hypertension in Brazil (unspecified route)